T1	Participants 26 70	HIV seropositive subjects with elevated TNF.
T2	Participants 235 260	HIV-seropositive patients
T3	Participants 518 550	persons with elevated TNF-alpha.
T4	Participants 551 651	Six HIV-seropositive subjects with elevated amounts of TNF-alpha in plasma at least at two occasions
